Zarcone Donna F's Form 4 filing
Cigna Group (CI) · filed Aug 12, 2021
- Accession no.
- 0001225208-21-011405
- Filed
- Aug 12, 2021
- Trade date
- Aug 10-11, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $210.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zarcone Donna FCIK 0001243083 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Common Stock, $.01 Par Value | PPurchaseAcquired | +500 | $209.89 | +$104,945 | 25,702 | Direct | |
| Aug 11, 2021 | Common Stock, $.01 Par Value | PPurchaseAcquired | +500 | $211.59 | +$105,795 | 26,202 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.